Evidence-based practice in women’s health: hormone therapy for women at menopause

✍ Scribed by Mary Ellen Rousseau

• Publisher: Elsevier Science
• Year: 2001
• Tongue: English
• Weight: 88 KB
• Volume: 46
• Category: Article
• ISSN: 1526-9523
• DOI: 10.1016/s1526-9523(01)00116-7

✦ Synopsis

Women's health providers, especially midwives, must take into account the known benefits and risks, as well as the “unknown,” when recommending the use of hormone therapy for menopausal women, especially as it relates to heart disease, breast cancer, impaired cognition, and osteoporosis. The most recent evidence available from various studies about the benefits and risks of estrogen and hormone therapy at menopause suggests that, although hormone therapy may be protective in some women against heart disease and osteoporosis, evidence is less certain about the benefits of hormone protection against impaired cognition and the risks of breast cancer with use. The clinical approach used by midwives in which individualizing care based on each woman's health status history as well as preferences is highly appropriate for women in the perimenopausal and menopausal period.